NCT00497198View on ClinicalTrials.gov

Efficacy and Safety Study of MCI-196 in Patients With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

183

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

September 30, 2007

Conditions
Type 2 Diabetes
Interventions
DRUG

MCI-196

Three tablets of MCI-196 500mg tablet at a time, three times daily, 12 weeks administration (dose in a day: 4500mg)

DRUG

Placebo of MCI-196 Tablet

Three tablets of Placebo tablet at a time, three times daily, 12 weeks administration

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY